Emergence of drug resistance limits the efficacy of HIV drugs, which currently requires life-long administration. In vitro high-throughput screening for competition with a broadly neutralizing antibody of HIV identified a small molecule that extends the strategies for targeting HIV.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Phillips, A. N. et al. Lancet HIV 1, e85–e93 (2014).
Xiao, T. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-020-0496-y (2020).
Salzwedel, K., West, J. T. & Hunter, E. J. Virol. 73, 2469–2480 (1999).
Huang, J. et al. Nature 491, 406–412 (2012).
Lu, L., Yu, F., Cai, L., Debnath, A. K. & Jiang, S. Curr. Top. Med. Chem. 16, 1074–1090 (2016).
Mulangu, S. et al. N. Engl. J. Med. 381, 2293–2303 (2019).
Jiang, S. et al. Lancet https://doi.org/10.1016/S0140-6736(20)30419-0 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Su, S., Jiang, S. Anti-HIV agents inspired by antibodies. Nat Chem Biol 16, 483–484 (2020). https://doi.org/10.1038/s41589-020-0521-1
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41589-020-0521-1
This article is cited by
-
The conformational epitope of a gp41-specific mucosal protective IgA binds to the HIV-1 envelope and neutralizes infection
Acta Pharmacologica Sinica (2025)